All products
By area
By ATC classifier
! Pharmacovigilance

UKRLIV suspension

The active substance:


Indications for use:

Symptomatic treatment of primary biliary cirrhosis (PBC) in absence of decompensated liver cirrhosis;

Dissolution of X-ray contrast cholesterol gallstones with diameter no more than 15 mm in patients with functioning gallbladder, despite presence of bilestone(s) in it.

5 mL of suspension contains 250 mg of ursodeoxycholic acid; Drugs used to treat liver and biliary tract. Drugs used in case of biliary pathology.

For detailed information, please see instruction for medical use.